Fresherslive Current Affairs;

USFDA approved Lupins Lurasidone Hydrochloride drug

Last Updated: January 8, 2019

Free Current Affairs to Your Email
USFDA approved Lupins Lurasidone Hydrochloride drug

USFDA approved Lupins Lurasidone Hydrochloride drug

08 January 2019 Current Affairs:

Lupin, the major Drug maker, received the approval from United States Food & Drug Administration (USFDA), the U.S. health regulator, to market Lurasidone Hydrochloride tablets in the U.S. 
The firm can sell its product in strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg. The drug is a generic version of Sunovion Pharmaceuticals Inc.’s Latuda tablets. The drug is indicated for conditions such as schizophrenia and bipolar depression.
United States Food & Drug Administration (USFDA):
♦ Established on: June 30, 1906
♦ Headquarters: Maryland, United States
USFDA is a federal agency of the United States Department of Health and Human Services
It is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, dietary supplements, vaccines, biopharmaceuticals, blood transfusions, medical devices, Electromagnetic Radiation Emitting Devices (ERED), cosmetics, animal foods & feed and veterinary products

Fresherslive Current Affairs;

Daily Current Affairs 2019

Fresherslive Current Affairs;


Subscribe to Current Affairs

Enter your email to get daily Current Affairs
Current Affairs PDF

Current Affairs 2019 October

October 15
News Quiz
October 14
News Quiz
October 13
News Quiz
October 12
News Quiz

Current Affairs 2019 September

September 30
News Quiz
September 29
News Quiz
September 28
News Quiz
September 27
News Quiz

Current Affairs 2019 August

August 31
News Quiz
August 30
News Quiz
August 29
News Quiz
August 28
News Quiz